Catalina Capital Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Catalina Capital Group's AMGN Position: Q2 2025 in Review
Catalina Capital Group sold out of Amgen (AMGN) in Q2 2025, closing a stake of 870 shares — an estimated $271K sold.
Catalina Capital Group first reported a position in AMGN in Q4 2023 and held it in 6 quarters. The position peaked at $751K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Catalina Capital Group reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- Catalina Capital Group sold 870 Amgen shares in Q2 2025, an estimated $271K.
- Catalina Capital Group first reported a position in Amgen in Q4 2023 and held it in 6 quarters.
- Catalina Capital Group's Amgen position peaked at $751K in Q3 2024.
- 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Catalina Capital Group's 13F filing for Q2 2025, filed 21 Jul 2025.